Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Z2UW
|
|||
Former ID |
DIB012160
|
|||
Drug Name |
Nicaraven
|
|||
Synonyms |
AVS; Antevan; Antevas
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Cerebrovascular disease [ICD-11: 8B2Z; ICD-10: I60-I69] | Phase 3 | [1] | |
Company |
Chugai Pharmaceutical
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H16N4O2
|
|||
Canonical SMILES |
CC(CNC(=O)C1=CN=CC=C1)NC(=O)C2=CN=CC=C2
|
|||
InChI |
1S/C15H16N4O2/c1-11(19-15(21)13-5-3-7-17-10-13)8-18-14(20)12-4-2-6-16-9-12/h2-7,9-11H,8H2,1H3,(H,18,20)(H,19,21)
|
|||
InChIKey |
KTXBOOWDLPUROC-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 79455-30-4
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Poly [ADP-ribose] polymerase 1 (PARP1) | Target Info | Modulator | [1] |
KEGG Pathway | Base excision repair | |||
NF-kappa B signaling pathway | ||||
Panther Pathway | FAS signaling pathway | |||
Pathway Interaction Database | Integrin-linked kinase signaling | |||
Caspase Cascade in Apoptosis | ||||
Notch-mediated HES/HEY network | ||||
Reactome | Dual Incision in GG-NER | |||
WikiPathways | FAS pathway and Stress induction of HSP regulation | |||
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | ||||
Nanoparticle triggered regulated necrosis | ||||
Corticotropin-releasing hormone |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibition of poly (ADP-ribose) polymerase as a protective effect of nicaraven in ionizing radiation- and ara-C-induced cell death. Anticancer Res. 2006 Sep-Oct;26(5A):3421-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.